Vasomune Therapeutics is a private biotechnology company developing the next generation of medicine. Our innovative approach focuses on combating vascular dysfunction and defending against illness by activating the Tie2 pathway
Our company’s lead drug candidate targets a signaling molecule responsible for regulating the vascular response to injury (vascular leak) which is associated with a wide range of diseases such as Acute Respiratory Distress Syndrome (ARDS), Acute Kidney Injury, sepsis and Cardiopulmonary Bypass. Through pioneering the fight against vascular leak and by decreasing the activity of multiple proinflammatory factors, we can greatly increase the chances of patient health and success. For more, visit www.vasomune.com
Company Details
- Employees
- 9
- Founded
- -
- Address
- 180 John St,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- vasomune.com
- HQ
- Toronto, Ontario
Vasomune Therapeutics, Inc. Questions
Vasomune Therapeutics, Inc.'s website is vasomune.com
Vasomune Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/vasomune-therapeutics
Vasomune Therapeutics, Inc. has
9 employees.
View email and phone details for 9
employees at Vasomune Therapeutics, Inc..
Vasomune Therapeutics, Inc.'s industry is
Pharmaceutical Manufacturing
Vasomune Therapeutics, Inc.'s top competitors are
Satellos Bioscience,
Appili Therapeutics,
Triumvira Immunologics, Inc.,
Medicenna Therapeutics Corp.,
Antibe Therapeutics Inc.,
Virica Biotech,
Notch Therapeutics,
Bluerock Therapeutics,
Tiap - Toronto Innovation Acceleration Partners,
Radiant Biotherapeutics.
Vasomune Therapeutics, Inc.'s categories are Pharmaceutical Manufacturing
Vasomune Therapeutics, Inc.'s founding year is 2014
